Open Access – No Login Required – Please Share with Your Colleagues!
February 2017 Global Forum Now Online
Product safety is one of our biggest responsibilities. “Product safety,” however, is really “patient safety” – the safety of patients who use these drugs, devices or related products. DIA’s February Global Forum lays out the global state of drug safety and pharmacovigilance for you:
- Podcast interview with FDA's Dr. Gerald Dal Pan
- Brexit's Implications for Pharmacovigilance within the UK and Europe
- A Message from DIA President Dr. Tatsuo Kurokawa: "The Glory of Drug Safety"
- SWOT Analysis of the Pharmacovigilance Programme of India
New in this issue: DIA Community Spotlight: Meet the Clinical Safety & Pharmacovigilance Community
Listen to our exclusive podcast interviews with experts from DIA EuroMeeting 2017: Co-Chair Dr. Ian Hudson, Chief Executive, MHRA; Hans-Georg Eichler, Senior Medical Officer, EMA; Claes Buxfeldt, Global Price and Reimbursement Director, AstraZeneca, and Ana Palma, Global HTA and Patient Access Lead, Sobi - all in your new Global Forum!